[A study of fibrinolytic therapy in glomerulonephritis and nephrotic syndrome. III. Indication, time to start therapy and criteria of effect (author's transl)].
D010450:Endopeptidases / Q000627:therapeutic use*; D005342:Fibrinolysis / Q000187:drug effects; D005921:Glomerulonephritis / Q000188:drug therapy*; D006801:Humans; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator